Latest filing published 10 Aug 2026 for Entrada Therapeutics, Inc., €1.9M.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
5AM Ventures V, L.P.: trading record in brief
5AM Ventures V, L.P. discloses dealings in Entrada Therapeutics, Inc. to SEC (Form 4). Activity is concentrated on a single trading day, 30 July 2026, with 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 10 August 2026, the filings show a transaction worth €1.9M in Entrada Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to 5AM Ventures V, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 331,156 shares@ US$6.55Common StockSEC144:0001674324-26-000008
- 331,156 shares@ US$6.550.96% mcap44.3% of flowCommon StockSEC144:0001674324-26-000006
2 of 2 declarations
